Meet Leonardo Lustgarten, Medical Director and Lead, Neurosurgery and Neuro-Oncology. He's in San Diego for the AACR Annual Meeting.

Stop by Booth 719 or visit us online to learn more about our therapy. tumortreatingfieldstherapy.com

#WeAreNovocure #TTFields #AACR24 #oncology

Today we announced that 20 presentations on Tumor Treating Fields (TTFields) therapy will be delivered at the American Association for Cancer Research (AACR) Annual Meeting 2024, to be held April 5 to 10 in San Diego. novocure.com/novocure-annou…

#AACR24 #TTFields #oncology

We will report financial results for the first quarter 2024 on Thursday, May 2, 2024, before the U.S. financial markets open. novocure.com/novocure-to-re… #earnings #oncology

What a week at the European Lung Cancer Congress! Our team appreciated the chance to exchange insights with cancer specialists and discuss the principles of our innovative Tumor Treating Fields (TTFields) therapy.

Learn more about us: novocure.com/about-us
#ELCC24 #ESMO #IASLC

Meet Christian Kruhl, MD. He is at the European Lung Cancer Congress this week in Prague.

Visit Christian and our team at Stand 2E2 in the Congress Hall Foyer to learn more about our innovative Tumor Treating Fields therapy.
#ELCC24 #TTFields

tumortreatingfieldstherapy.com

We are excited to participate in #ELCC24 this week in Prague. We look forward to learning from oncology experts and raising awareness of our innovative Tumor Treating Fields (TTFields) therapy.

Learn more about #TTFields : tumortreatingfieldstherapy.com
#WeAreNovocure #ESMO #IASLC

Patients, caregivers and their families are at the heart of our mission. That is why we are proud to support the “Empowering Caregivers” webinar from American Brain Tumor Association. If you are a #caregiver or know one, learn more. bit.ly/MarchPFM2024 #patientforward #BTSM

A late breaking abstract with results of an exploratory subgroup analysis of the phase 3 ENGOT-ov50 / GOG-3029 / INNOVATE-3 clinical trial was selected as a best oral presentation and shared yesterday at the ESGO 2024 Congress. #ESGO2024 novocure.com/innovate-3-lat…

Today, we reported financial results for the quarter and full year ended December 31, 2023. Learn more: novocure.com/novocure-repor…

This month, PanCAN is sharing educational resources, research, and highlights on how the #pancreaticcancer community is addressing health inequities and improving the lives of everyone touched by this disease. Learn more at pancan.org/blackcommunity

We are proud to continue supporting the Head For The Cure Foundation in their work of raising awareness of brain cancer and inspiring hope for patients and caregivers. We are making a difference together. #braincancer #glioblastoma

We started 24 years ago based on the idea that electric fields at very specific frequencies could be harnessed to treat cancer. Now, we are a global oncology company with a mission to extend survival in some of the most aggressive forms of cancer. #WeAreNovocure #NovocureDay

Today is #WorldCancerDay , a reminder that we all have the power to reduce the impact of cancer – for ourselves, the people we love, and the world. Together, let’s continue to take action to make a difference in cancer. #oncology #medtech #CloseTheCareGap #patientforward